Related Experiment Video

Updated: Mar 8, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

10.3K

The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain

W A García-Suástegui1, L A Ramos-Chávez2, M Rubio-Osornio3

  • 1Departamento de Biología y Toxicología de la Reproducción, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, 72000 Heroica Puebla de Zaragoza, PUE, Mexico.

Oxidative Medicine and Cellular Longevity
|February 7, 2017
PubMed

Insights

The brain detoxifies harmful agents using metabolic pathways, similar to the liver. This review explores the role of Cytochrome P450 family 2 subfamily E member 1 (CYP2E1) in brain health and alcohol-related disorders.

Area of Science:

  • Neuroscience
  • Toxicology
  • Biochemistry

Background:

  • Detoxification occurs in multiple tissues, not just the liver.
  • The brain possesses metabolic pathways for eliminating xenobiotics.
  • Cytochrome P450 family 2 subfamily E member 1 (CYP2E1) plays a role in detoxifying harmful compounds and is implicated in various diseases.

Purpose of the Study:

  • To review the presence and induction of CYP2E1 in brain regions.
  • To explore the link between CYP2E1 and brain disorders.
  • To examine the behavioral aspects of alcohol consumption related to CYP2E1 metabolism.

Main Methods:

  • Literature review on CYP2E1 presence, induction, and function in the brain.
  • Analysis of studies linking CYP2E1 to neurological conditions.
  • Examination of research on CYP2E1's role in alcohol metabolism and behavior.

Main Results:

  • CYP2E1, a phase I monooxygenase, is present in various brain regions.
  • Conditions influencing CYP2E1 protein, mRNA, and activity levels were identified.
  • Evidence suggests a connection between CYP2E1 and brain disorders, including alcohol-related behaviors.

Conclusions:

  • CYP2E1 is an important enzyme in brain detoxification processes.
  • Understanding CYP2E1's role in the brain is crucial for addressing neurological and behavioral disorders.
  • Further research into CYP2E1 metabolism in the brain may offer therapeutic insights.

More Related Videos

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

14.4K
Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells06:15

Evaluation of Bioenergetic Function in Cerebral Vascular Endothelial Cells

Published on: November 19, 2016

9.7K

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
79
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
5.4K
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
77
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
4.6K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
4.0K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
5.4K